Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Co-Arinate vs Praziquantel for Urinary Schistosomiasis in Children
NCT00510159Phase 3Completed
- Sponsor
- Dafra Pharma
- Start
- Aug 2007
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of artesunate + sulfamethoxypyrazine + pyrimethamine in urinary schistosomiasis (2 arms), sponsored by Dafra Pharma. Primary endpoints: Parasite load at 28 days, Amount of eggs produced at 28 days and 1 more. Started Aug 2007; status: completed.
02
Drugs
artesunate + sulfamethoxypyrazine + pyrimethamine
03
Conditions
urinary schistosomiasis
Beyond the preview
Go deeper on NCT00510159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00510159.